SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Novel Drug Delivery Systems to Treat Mild Traumatic Brain Injury Based on Carbon Nanotubes, University of Texas Health Science Center, University of Texas Medical Branch, Baylor College of Medicine, Rice University and Transitional Learning Center
August 25, 2008
 · 
1 min read
Lone Star Bio
Molecule That Keeps Pathogens Like Salmonella In Check Uncovered, University of Texas Southwestern Medical Center Study; New Antibiotic May Block Toxins From Bacteria
August 22, 2008
 · 
1 min read
Lone Star Bio
Researchers Uncover Attack Mechanism Of Illness-inducing Bacterium, University of Texas Southwestern Medical Center Study
August 20, 2008
 · 
1 min read
Drug Development
Eli Lilly and Company Impotence Drug Treats Prostate Enlargement, University of Texas Southwestern Medical Center and Northwestern University Study
August 19, 2008
 · 
1 min read
Lone Star Bio
Model For Neurological Disorder ‘Angelman Syndrome’ Developed, University of Texas Study
August 15, 2008
 · 
1 min read
Lone Star Bio
Sensitivity To Antidepressants Linked With Trkb-Mediated Neural Proliferation, University of Texas Southwestern Medical Center Study
August 14, 2008
 · 
1 min read
Lone Star Bio
Tiny Molecule Helps Control Blood-vessel Development, University of Texas Southwestern Medical Center Study
August 13, 2008
 · 
1 min read
Lone Star Bio
Risk of Breast Cancer Relapse Can Linger, University of Texas M. D. Anderson Cancer Center Study
August 13, 2008
 · 
1 min read
Bio NC
‘Lost Tribe’ Of Clinician-scientists: Medical Doctors Who Do Research Could Be A Dying Breed
August 12, 2008
 · 
1 min read
Lone Star Bio
New Therapy Freezes Out Esophageal Cancers; Cryoablation Attractive Option For Older Patients With Other Medical Issues, University of Texas Southwestern Medical Center Team Says
August 11, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More